title: Management of atrial fibrillation in patients with hypertension.
abstract: Atrial fibrillation (AF) is a common arrhythmia in patients with hypertensive heart disease. In addition, the presence of hypertension in patients with AF constitutes an important risk factor for the development of thromboembolic events and probably also selects out those individuals who may be resistant to drug therapy. AF in patients with hypertensive heart disease may lead to a number of serious clinical sequelae including stroke, left atrial myopathy, left ventricular dysfunction, and congestive heart failure. This needs to be treated aggressively since many patients may become quite symptomatic when AF develops in the setting of diastolic and systolic dysfunction, regular features of hypertensive heart disease. There are several treatment approaches that may be considered in such patients ranging from interventions to prevent thromboembolic events, drugs and procedures for control of the ventricular response, and drug and non-pharmacologic therapy specifically designed to prevent AF or to restore normal sinus rhythm. This review article will cover each of these components of therapy of AF and will attempt to focus on those therapies that might be best suited for patients with hypertensive heart disease.
authors.affiliation: Cardiovascular Division, The Lankenau Hospital and Medical Research Center, Wynnewood, PA, USA.
authors.forename: P R
authors.initials: PR
authors.lastname: Kowey
authors.forename: R A
authors.initials: RA
authors.lastname: Marinchak
authors.forename: S J
authors.initials: SJ
authors.lastname: Rials
authors.forename: R A
authors.initials: RA
authors.lastname: Filart
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D006973:Hypertension / Q000150:complications*; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control
chemical_list: D000925:Anticoagulants